AirSculpt Strengthens Balance Sheet with $10.0 Million Debt Paydown

MIAMI BEACH, Fla., June 16, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. ("AirSculpt") (NASDAQ:AIRS), a national provider of premium body contouring procedures, today announced the voluntary prepayment of $10.0 million of its outstanding term loan debt using cash on hand, following the successful completion of its offering of 3,634,000 shares of common stock, which generated net proceeds, after estimated expenses, of approximately $13.8 million. The Company noted that with this financing and assuming no significant changes in the current macroeconomic environment, it does not anticipate the need for additional material capital raises this year.

Commenting on the announcement, Yogi Jashnani, Chief Executive Officer, stated: "On the heels of our successful offering of common stock, we are pleased to apply a substantial portion of the proceeds to prepay $10.0 million in our outstanding debt. As a result, we move forward with an improved capital structure and enhanced financial flexibility. This will enable us to implement the strategic priorities that advance our transformation, helping position us to deliver sustained long-term growth in revenue and profitability."

Following the completion of its offering of common stock, the Company now has 62,436,670 shares of common stock outstanding. Additionally, the Company will have full availability of $5.0 million under its revolving credit facility, after completing the remaining payment of $2.9 million on the outstanding principal on June 16, 2025.    

About AirSculpt

AirSculpt is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, ...